ALK Rearrangement in a Large Series of Consecutive Non–Small Cell Lung Cancers: Comparison Between a New Immunohistochemical Approach and Fluorescence In Situ Hybridization for the Screening of Patients Eligible for Crizotinib Treatment

Alessandro Ribechini, Federico Cappuzzo, Franca Melfi, Marco Lucchi, Alfredo Mussi, Gabriella Fontanini, Greta Alì, Agnese Proietti, Serena Pelliccioni, Cristina Niccoli, Cristiana Lupi, Elisa Sensi, Riccardo Giannini, Nicla Borrelli, Maura Menghi, Antonio Chella
  • Archives of Pathology & Laboratory Medicine, November 2014, Archives of Pathology and Laboratory Medicine
  • DOI: 10.5858/arpa.2013-0388-oa

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Federico Cappuzzo